Archive
Past newsletters of MDDR.
Thursday, 16 July 2026
New AI Office launched, Pharmacy Guild under fire, Racist leaflet targets GPs
Prime Minister Anthony Albanese announced the creation of a new Office of AI within the Department of the Prime Minister and Cabinet, aimed
Wednesday, 15 July 2026
NHS sepsis monitoring pilot, Ebola vaccine trial begins, Gonorrhoea vaccine effectiveness
The NHS plans to provide wearable devices to patients at risk of sepsis to monitor vital signs such as blood pressure and heart rate at home
Tuesday, 14 July 2026
RACGP presidential candidates announced, Pharmacy policy report critiques, Vic Libs promise payroll tax relief
Dr Ramya Raman and Dr Anita Muñoz have declared their intentions to run for the RACGP presidency in the upcoming election. Dr Raman, the cur
Monday, 13 July 2026
Clinical supply chain podcast series, Patient-centred hospital design insights, Challenging norms in mental health care
A new six-part podcast series from Almac Clinical Services delves into the complexities of clinical trial supply chains. It covers the journ
Sunday, 12 July 2026
Children's health in policy focus, UK resident doctors' pay deal, New UN HIV/AIDS declaration
A global initiative, Children in All Policies 2030, aims to integrate children's needs and rights into public policies, addressing gaps iden
Saturday, 11 July 2026
Contraceptive safety update, Bulk billing rules under scrutiny, TGA alerts on sexual products
The Pharmacovigilance Risk Assessment Committee (PRAC) has released new safety information regarding desogestrel- and etonogestrel-containin
Friday, 10 July 2026
AIHW data coordination call, Endoscopic procedure for weight, Injecting room reduces ambulance callouts
The Australian Institute of Health and Welfare (AIHW) emphasises the need for better data coordination in general practice to address the si
Thursday, 9 July 2026
PBS adrenaline prescription changes, Leadership needed for health reform, Interim GP clinic reopening in Clermont
The Pharmaceutical Benefits Advisory Committee has revoked special dispensation allowing GPs to initiate PBS-eligible adrenaline prescriptio
Wednesday, 8 July 2026
Endometriosis diagnosis tests recommended, Daraxonrasib review for pancreatic cancer, Insulin cost analysis post-cap
Two non-invasive tests have been recommended by the National Institute for Health and Care Excellence (NICE) to expedite the diagnosis of en
Tuesday, 7 July 2026
Pharmacist prescribing evidence questioned, New split billing regulations proposed, AMA presidential candidates announced
A new report from the Sax Institute reveals significant uncertainties regarding the evidence supporting pharmacist-led prescribing in Austra